Young-onset type 2 diabetes in South Korea: a review of the current status and unmet need
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, Ye Seul | - |
dc.contributor.author | Han, Kyungdo | - |
dc.contributor.author | Sohn, Tae Seo | - |
dc.contributor.author | Kim, Nam Hoon | - |
dc.date.accessioned | 2022-02-24T17:40:57Z | - |
dc.date.available | 2022-02-24T17:40:57Z | - |
dc.date.created | 2022-02-07 | - |
dc.date.issued | 2021-09 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/136766 | - |
dc.description.abstract | The prevalence of young-onset (diagnosis at age < 40 years) type 2 diabetes mellitus (T2DM) is increasing globally. Young-onset T2DM has a common pathophysiology of glucose dysregulation as in late-onset T2DM. However, it presents a greater association with obesity and a more rapid decline in beta-cell function than late-onset T2DM. Accumulating evidence indicates that disease progression in young-onset T2DM is rapid, resulting in early and frequent development of microvascular and macrovascular complications, as well as premature death. Improper management and low adherence to medical therapy are important issues in young-onset T2DM. This review discusses the epidemiology, disease entity, and clinical issues associated with young-onset T2DM. We also present the prevalence and clinical characteristics of patients with young-onset T2DM in South Korea. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ASSOC INTERNAL MEDICINE | - |
dc.subject | COMPLICATIONS | - |
dc.subject | RISK | - |
dc.subject | AGE | - |
dc.subject | ADOLESCENTS | - |
dc.subject | PREVALENCE | - |
dc.subject | ADHERENCE | - |
dc.subject | ADULTS | - |
dc.subject | POPULATION | - |
dc.subject | MEDICATION | - |
dc.subject | MORTALITY | - |
dc.title | Young-onset type 2 diabetes in South Korea: a review of the current status and unmet need | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Nam Hoon | - |
dc.identifier.doi | 10.3904/kjim.2021.379 | - |
dc.identifier.scopusid | 2-s2.0-85115952594 | - |
dc.identifier.wosid | 000701299600003 | - |
dc.identifier.bibliographicCitation | KOREAN JOURNAL OF INTERNAL MEDICINE, v.36, no.5, pp.1049 - 1058 | - |
dc.relation.isPartOf | KOREAN JOURNAL OF INTERNAL MEDICINE | - |
dc.citation.title | KOREAN JOURNAL OF INTERNAL MEDICINE | - |
dc.citation.volume | 36 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 1049 | - |
dc.citation.endPage | 1058 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002748953 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | ADHERENCE | - |
dc.subject.keywordPlus | ADOLESCENTS | - |
dc.subject.keywordPlus | ADULTS | - |
dc.subject.keywordPlus | AGE | - |
dc.subject.keywordPlus | COMPLICATIONS | - |
dc.subject.keywordPlus | MEDICATION | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | POPULATION | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | Diabetes complications | - |
dc.subject.keywordAuthor | Diabetes mellitus | - |
dc.subject.keywordAuthor | Epidemiology | - |
dc.subject.keywordAuthor | Treatment adherence and compliance | - |
dc.subject.keywordAuthor | Young adult | - |
dc.subject.keywordAuthor | type 2 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.